Viatris (VTRS) Stock Forecast, Price Target & Predictions
VTRS Stock Forecast
Viatris stock forecast is as follows: an average price target of $13.75 (represents a 20.09% upside from VTRS’s last price of $11.45) and a rating consensus of 'Hold', based on 7 wall street analysts offering a 1-year stock forecast.
VTRS Price Target
The average price target for Viatris (VTRS) is $13.75 based on 1-year price targets from 7 Wall Street analysts in the past 3 months, with a price target range of $15.00 to $12.00. This represents a potential 20.09% upside from VTRS's last price of $11.45.
VTRS Analyst Ratings
According to 7 Wall Street analysts, Viatris's rating consensus is 'Hold'. The analyst rating breakdown for VTRS stock is 0 'Strong Buy' (0.00%), 1 'Buy' (14.29%), 5 'Hold' (71.43%), 1 'Sell' (14.29%), and 0 'Strong Sell' (0.00%).
Viatris Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jul 19, 2024 | Glen Santangelo | Jefferies | $15.00 | $11.77 | 27.44% | 31.00% |
| Mar 28, 2024 | David Amsellem | Piper Sandler | $13.00 | $11.83 | 9.89% | 13.54% |
| Jun 26, 2023 | David Amsellem | Piper Sandler | $10.00 | $9.84 | 1.68% | -12.66% |
| Feb 01, 2023 | - | Barclays | $15.00 | $12.16 | 23.36% | 31.00% |
| Nov 09, 2022 | Ashwani Verma | UBS | $12.00 | $10.83 | 10.80% | 4.80% |
| Jun 13, 2022 | Ashwani Verma | UBS | $9.00 | $10.77 | -16.43% | -21.40% |
The latest Viatris stock forecast, released on Jul 19, 2024 by Glen Santangelo from Jefferies, set a price target of $15.00, which represents a 27.44% increase from the stock price at the time of the forecast ($11.77), and a 31.00% increase from VTRS last price ($11.45).
Viatris Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 2 |
| Avg Price Target | - | - | $14.00 |
| Last Closing Price | $11.45 | $11.45 | $11.45 |
| Upside/Downside | -100.00% | -100.00% | 22.27% |
In the current month, the average price target of Viatris stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Viatris's last price of $11.45. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Mar 28, 2024 | Piper Sandler | Neutral | Neutral | Hold |
| Jan 12, 2024 | Cowen & Co. | - | Market Perform | Downgrade |
| Dec 27, 2023 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
| Sep 27, 2023 | Wells Fargo | Equal-Weight | Equal-Weight | Hold |
| Jun 26, 2023 | BMO Capital | Perform | Market Perform | Downgrade |
| Feb 17, 2023 | BMO Capital | Market Perform | Perform | Downgrade |
| Feb 17, 2023 | BMO Capital | - | Market Perform | Downgrade |
| Feb 01, 2023 | Barclays | Overweight | Overweight | Hold |
| Nov 08, 2022 | Piper Sandler | - | Neutral | Upgrade |
| Jun 13, 2022 | UBS | - | Sell | Initialise |
Viatris's last stock rating was published by Piper Sandler on Mar 28, 2024. The company gave VTRS a "Neutral" rating, the same as its previous rate.
Viatris Financial Forecast
Viatris Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | $3.94B | $3.92B | $3.73B | $3.88B | $4.08B | $4.12B | $4.19B | $4.34B | $4.54B | $4.58B | $4.43B | $3.62B | $2.97B | $2.73B | $2.62B | $3.19B | $2.96B | $2.85B | $2.50B | $2.68B | $2.72B |
| Avg Forecast | $3.60B | $3.64B | $3.64B | $3.54B | $3.62B | $3.72B | $3.78B | $3.69B | $3.89B | $4.00B | $3.86B | $3.80B | $3.99B | $4.14B | $4.18B | $4.23B | $4.35B | $4.39B | $4.40B | $4.20B | $4.17B | $3.00B | $2.74B | $2.65B | $3.22B | $3.01B | $2.81B | $2.69B | $2.68B | $2.69B |
| High Forecast | $3.60B | $3.64B | $3.64B | $3.54B | $3.62B | $3.76B | $3.78B | $3.69B | $3.95B | $4.00B | $3.86B | $3.80B | $3.99B | $4.14B | $4.18B | $4.23B | $4.35B | $4.39B | $4.40B | $4.20B | $4.17B | $3.00B | $2.74B | $2.65B | $3.22B | $3.01B | $2.81B | $2.69B | $3.22B | $3.23B |
| Low Forecast | $3.60B | $3.64B | $3.64B | $3.54B | $3.62B | $3.69B | $3.78B | $3.69B | $3.84B | $4.00B | $3.86B | $3.80B | $3.99B | $4.14B | $4.18B | $4.23B | $4.35B | $4.39B | $4.40B | $4.20B | $4.17B | $3.00B | $2.74B | $2.65B | $3.22B | $3.01B | $2.81B | $2.69B | $2.15B | $2.15B |
| # Analysts | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 10 | 16 | 8 | 11 | 7 | 11 | 7 | 7 | 17 | 19 |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.99% | 1.01% | 0.98% | 0.97% | 0.99% | 0.98% | 0.99% | 1.00% | 1.03% | 1.04% | 1.06% | 0.87% | 0.99% | 1.00% | 0.99% | 0.99% | 0.98% | 1.01% | 0.93% | 1.00% | 1.01% |
Viatris's average Quarter revenue forecast for Dec 23 based on 4 analysts is $3.89B, with a low forecast of $3.84B, and a high forecast of $3.95B. VTRS's average Quarter revenue forecast represents a -1.40% decrease compared to the company's last Quarter revenue of $3.94B (Sep 23).
Viatris EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 10 | 16 | 8 | 11 | 7 | 11 | 7 | 7 | 17 | 19 |
| EBITDA | - | - | - | - | - | - | - | - | - | $451.70M | $369.20M | $470.30M | $1.64B | $576.80M | $546.10M | $679.90M | $963.20M | $1.37B | $1.30B | $1.17B | $148.90M | $801.30M | $571.50M | $581.00M | $812.80M | $732.10M | $601.80M | $513.50M | $641.30M | $624.00M |
| Avg Forecast | $953.49M | $963.13M | $962.86M | $938.05M | $959.31M | $984.02M | $1.00B | $1.45B | $1.03B | $1.06B | $1.02B | $1.32B | $790.19M | $1.10B | $1.11B | $1.20B | $1.15B | $1.16B | $1.17B | $977.67M | $1.11B | $794.78M | $724.43M | $539.29M | $852.54M | $796.45M | $744.52M | $497.56M | $640.70M | $618.50M |
| High Forecast | $953.49M | $963.13M | $962.86M | $938.05M | $959.31M | $994.72M | $1.00B | $1.74B | $1.05B | $1.06B | $1.02B | $1.59B | $948.23M | $1.10B | $1.11B | $1.44B | $1.15B | $1.16B | $1.17B | $1.17B | $1.11B | $794.78M | $724.43M | $647.15M | $852.54M | $796.45M | $744.52M | $597.07M | $768.84M | $742.20M |
| Low Forecast | $953.49M | $963.13M | $962.86M | $938.05M | $959.31M | $976.00M | $1.00B | $1.16B | $1.02B | $1.06B | $1.02B | $1.06B | $632.16M | $1.10B | $1.11B | $960.68M | $1.15B | $1.16B | $1.17B | $782.14M | $1.11B | $794.78M | $724.43M | $431.43M | $852.54M | $796.45M | $744.52M | $398.05M | $512.56M | $494.80M |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.43% | 0.36% | 0.36% | 2.08% | 0.53% | 0.49% | 0.57% | 0.84% | 1.18% | 1.11% | 1.20% | 0.13% | 1.01% | 0.79% | 1.08% | 0.95% | 0.92% | 0.81% | 1.03% | 1.00% | 1.01% |
4 analysts predict VTRS's average Quarter EBITDA for Dec 23 to be $1.03B, with a high of $1.05B and a low of $1.02B. This is 127.88% upper than Viatris's previous annual EBITDA (Sep 23) of $451.70M.
Viatris Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 10 | 16 | 8 | 11 | 7 | 11 | 7 | 7 | 17 | 19 |
| Net Income | - | - | - | - | - | - | - | - | - | $331.60M | $264.00M | $224.70M | $1.01B | $354.30M | $313.90M | $399.20M | $-263.80M | $311.50M | $-279.20M | $-1.04B | $-915.80M | $185.70M | $39.40M | $20.80M | $20.50M | $189.80M | $-168.50M | $-25.00M | $87.10M | $66.40M |
| Avg Forecast | $804.80M | $787.25M | $777.42M | $763.13M | $752.01M | $806.12M | $808.13M | $411.47M | $769.84M | $888.99M | $846.61M | $374.07M | $-300.67M | $997.45M | $988.76M | $340.06M | $986.80M | $1.05B | $1.04B | $-881.96M | $1.48B | $1.39B | $1.18B | $19.83M | $1.53B | $1.35B | $1.12B | $-24.05M | $87.10M | $65.68M |
| High Forecast | $804.80M | $787.25M | $777.42M | $763.13M | $752.01M | $841.69M | $808.40M | $493.77M | $804.31M | $892.78M | $846.61M | $448.88M | $-240.53M | $997.45M | $988.76M | $408.07M | $986.80M | $1.05B | $1.04B | $-705.57M | $1.48B | $1.39B | $1.18B | $23.80M | $1.53B | $1.35B | $1.12B | $-19.24M | $104.52M | $78.81M |
| Low Forecast | $804.80M | $787.25M | $777.42M | $763.13M | $752.01M | $758.71M | $807.85M | $329.18M | $700.90M | $885.20M | $846.61M | $299.25M | $-360.80M | $997.45M | $988.76M | $272.05M | $986.80M | $1.05B | $1.04B | $-1.06B | $1.48B | $1.39B | $1.18B | $15.87M | $1.53B | $1.35B | $1.12B | $-28.86M | $69.68M | $52.54M |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.37% | 0.31% | 0.60% | -3.36% | 0.36% | 0.32% | 1.17% | -0.27% | 0.30% | -0.27% | 1.18% | -0.62% | 0.13% | 0.03% | 1.05% | 0.01% | 0.14% | -0.15% | 1.04% | 1.00% | 1.01% |
Viatris's average Quarter net income forecast for Dec 23 is $769.84M, with a range of $700.90M to $804.31M. VTRS's average Quarter net income forecast represents a 132.16% increase compared to the company's last Quarter net income of $331.60M (Sep 23).
Viatris SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 10 | 16 | 8 | 11 | 7 | 11 | 7 | 7 | 17 | 19 |
| SG&A | - | - | - | - | - | - | - | - | - | $1.05B | $1.03B | $958.90M | $1.27B | $1.02B | $981.10M | $915.30M | $1.08B | $1.05B | $1.20B | $1.19B | $1.36B | $658.40M | $719.40M | $605.40M | $654.40M | $632.70M | $668.60M | $607.90M | $607.50M | $631.30M |
| Avg Forecast | $942.72M | $952.25M | $951.98M | $927.45M | $948.47M | $972.91M | $990.05M | $943.44M | $1.02B | $1.05B | $1.01B | $857.67M | $1.23B | $1.08B | $1.10B | $779.70M | $1.14B | $1.15B | $1.15B | $1.01B | $1.09B | $785.80M | $716.25M | $577.24M | $842.91M | $787.45M | $736.11M | $584.82M | $607.50M | $624.44M |
| High Forecast | $942.72M | $952.25M | $951.98M | $927.45M | $948.47M | $983.48M | $990.05M | $1.13B | $1.03B | $1.05B | $1.01B | $1.03B | $1.48B | $1.08B | $1.10B | $935.64M | $1.14B | $1.15B | $1.15B | $1.21B | $1.09B | $785.80M | $716.25M | $692.69M | $842.91M | $787.45M | $736.11M | $701.78M | $729.00M | $749.33M |
| Low Forecast | $942.72M | $952.25M | $951.98M | $927.45M | $948.47M | $964.97M | $990.05M | $754.75M | $1.00B | $1.05B | $1.01B | $686.14M | $987.40M | $1.08B | $1.10B | $623.76M | $1.14B | $1.15B | $1.15B | $806.82M | $1.09B | $785.80M | $716.25M | $461.79M | $842.91M | $787.45M | $736.11M | $467.85M | $486.00M | $499.55M |
| Surprise % | - | - | - | - | - | - | - | - | - | 1.01% | 1.02% | 1.12% | 1.03% | 0.94% | 0.90% | 1.17% | 0.95% | 0.92% | 1.05% | 1.18% | 1.25% | 0.84% | 1.00% | 1.05% | 0.78% | 0.80% | 0.91% | 1.04% | 1.00% | 1.01% |
Viatris's average Quarter SG&A projection for Dec 23 is $1.02B, based on 4 Wall Street analysts, with a range of $1.00B to $1.03B. The forecast indicates a -3.40% fall compared to VTRS last annual SG&A of $1.05B (Sep 23).
Viatris EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 10 | 16 | 8 | 11 | 7 | 11 | 7 | 7 | 17 | 19 |
| EPS | - | - | - | - | - | - | - | - | - | $0.28 | $0.22 | $0.19 | $0.83 | $0.29 | $0.26 | $0.33 | $-0.22 | $0.26 | $-0.23 | $-0.86 | $-0.76 | $0.36 | $0.08 | $0.04 | $0.04 | $0.37 | $-0.33 | $-0.05 | $0.17 | $0.12 |
| Avg Forecast | $0.68 | $0.66 | $0.65 | $0.64 | $0.63 | $0.68 | $0.68 | $0.67 | $0.65 | $0.75 | $0.71 | $0.69 | $0.72 | $0.84 | $0.83 | $0.83 | $0.83 | $0.88 | $0.87 | $0.80 | $1.24 | $1.16 | $0.99 | $0.86 | $1.29 | $1.13 | $0.94 | $0.79 | $0.96 | $0.91 |
| High Forecast | $0.68 | $0.66 | $0.65 | $0.64 | $0.63 | $0.71 | $0.68 | $0.67 | $0.68 | $0.75 | $0.71 | $0.69 | $0.72 | $0.84 | $0.83 | $0.83 | $0.83 | $0.88 | $0.87 | $0.80 | $1.24 | $1.16 | $0.99 | $0.86 | $1.29 | $1.13 | $0.94 | $0.79 | $1.15 | $1.09 |
| Low Forecast | $0.68 | $0.66 | $0.65 | $0.64 | $0.63 | $0.64 | $0.68 | $0.67 | $0.59 | $0.74 | $0.71 | $0.69 | $0.72 | $0.84 | $0.83 | $0.83 | $0.83 | $0.88 | $0.87 | $0.80 | $1.24 | $1.16 | $0.99 | $0.86 | $1.29 | $1.13 | $0.94 | $0.79 | $0.77 | $0.73 |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.38% | 0.31% | 0.28% | 1.16% | 0.35% | 0.31% | 0.40% | -0.27% | 0.29% | -0.26% | -1.08% | -0.61% | 0.31% | 0.08% | 0.05% | 0.03% | 0.33% | -0.35% | -0.06% | 0.18% | 0.13% |
According to 4 Wall Street analysts, Viatris's projected average Quarter EPS for Dec 23 is $0.65, with a low estimate of $0.59 and a high estimate of $0.68. This represents a 130.83% increase compared to VTRS previous annual EPS of $0.28 (Sep 23).
Viatris Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| EBS | Emergent BioSolutions | $8.77 | $51.50 | 487.23% | Buy |
| TLRY | Tilray Brands | $1.73 | $7.42 | 328.90% | Hold |
| ELAN | Elanco Animal Health | $12.56 | $26.50 | 110.99% | Buy |
| CTLT | Catalent | $58.69 | $76.40 | 30.18% | Hold |
| ZTS | Zoetis | $175.18 | $227.71 | 29.99% | Buy |
| LNTH | Lantheus | $115.45 | $146.25 | 26.68% | Buy |
| VTRS | Viatris | $11.45 | $13.75 | 20.09% | Hold |
| BHC | Bausch Health Companies | $9.26 | $10.00 | 7.99% | Hold |
| TEVA | Teva Pharmaceutical Industries | $18.64 | $20.00 | 7.30% | Buy |
| HCM | HUTCHMED (China) | $18.38 | $17.50 | -4.79% | Buy |
| HLN | Haleon | $9.76 | $9.15 | -6.25% | Buy |
VTRS Forecast FAQ
Is Viatris a good buy?
No, according to 7 Wall Street analysts, Viatris (VTRS) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 14.29% of VTRS's total ratings.
What is VTRS's price target?
Viatris (VTRS) average price target is $13.75 with a range of $12 to $15, implying a 20.09% from its last price of $11.45. The data is based on 7 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Viatris stock go up soon?
According to Wall Street analysts' prediction for VTRS stock, the company can go up by 20.09% (from the last price of $11.45 to the average price target of $13.75), up by 31.00% based on the highest stock price target, and up by 4.80% based on the lowest stock price target.
Can Viatris stock reach $20?
VTRS's average twelve months analyst stock price target of $13.75 does not support the claim that Viatris can reach $20 in the near future.
What are Viatris's analysts' financial forecasts?
Viatris's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $14.81B (high $14.85B, low $14.78B), average EBITDA is $4.4B (high $4.7B, low $4.1B), average net income is $2.78B (high $2.9B, low $2.65B), average SG&A $3.85B (high $4.05B, low $3.66B), and average EPS is $2.66 (high $2.69, low $2.62). VTRS's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $14.41B (high $14.41B, low $14.41B), average EBITDA is $3.82B (high $3.82B, low $3.82B), average net income is $3.13B (high $3.13B, low $3.13B), average SG&A $3.77B (high $3.77B, low $3.77B), and average EPS is $2.63 (high $2.63, low $2.63).
Did the VTRS's actual financial results beat the analysts' financial forecasts?
Based on Viatris's last annual report (Dec 2022), the company's revenue was $16.26B, which missed the average analysts forecast of $16.54B by -1.69%. Apple's EBITDA was $3.45B, missing the average prediction of $4.19B by -17.84%. The company's net income was $2.08B, beating the average estimation of $2.03B by 2.62%. Apple's SG&A was $4.18B, missing the average forecast of $4.19B by -0.33%. Lastly, the company's EPS was $1.71, missing the average prediction of $3.21 by -46.74%. In terms of the last quarterly report (Sep 2023), Viatris's revenue was $3.94B, missing the average analysts' forecast of $4B by -1.47%. The company's EBITDA was $451.7M, missing the average prediction of $1.06B by -57.37%. Viatris's net income was $331.6M, missing the average estimation of $888.99M by -62.70%. The company's SG&A was $1.05B, beating the average forecast of $1.05B by 0.56%. Lastly, the company's EPS was $0.28, missing the average prediction of $0.746 by -62.48%